GE HealthCare Technologies Inc. (GEHC)
Nasdaq · Healthcare · Medical Devices
$65.74+2.26%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $29.7B
- P/E (trailing)
- 15.1
- Forward P/E
- 12.2
- Dividend yield
- 0.2%
- 52-week range
- $58.75 – $89.77
- 52-week change
- −13.69%
- EPS (trailing)
- $4.35
- Analyst rating
- 1.8 Buy
- Next earnings
- Oct 28, 2026
Fiscal year to Dec 2025
- Revenue
- $20.6B (+4.84%)
- Net income
- $2.1B
- Operating margin
- 13.4%
- Diluted EPS
- $4.55
From the company’s annual report on SEC EDGAR.
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products.
Headquarters: Chicago, United States · 54,000 employees · gehealthcare.com